These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 28615273)

  • 21. Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
    Buder S; Dudareva S; Jansen K; Loenenbach A; Nikisins S; Sailer A; Guhl E; Kohl PK; Bremer V;
    BMC Infect Dis; 2018 Jan; 18(1):44. PubMed ID: 29343220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial susceptibility in
    Latif AS; Gwanzura L; Machiha A; Ndowa F; Tarupiwa A; Gudza-Mugabe M; Shukusho FD; Chakanyuka Musanhu C; Wi T; Unemo M
    Sex Transm Infect; 2018 Feb; 94(1):62-66. PubMed ID: 28476914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between In vitro susceptibility and treatment outcome with azithromycin in gonorrhoea: a prospective study.
    Khaki P; Bhalla P; Sharma A; Kumar V
    Indian J Med Microbiol; 2007 Oct; 25(4):354-7. PubMed ID: 18087084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
    Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
    Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends of resistance to antimicrobials recommended currently and in the past for management of gonorrhea in the Apex STD center in India and comparison of antimicrobial resistance profile between 2002-2006 and 2007-2012.
    Bala M; Singh V; Bhargava A; Ramesh V
    Sex Transm Dis; 2015 Apr; 42(4):218-22. PubMed ID: 25763675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gentamicin as an alternative to ceftriaxone in the treatment of gonorrhoea: the G-TOG non-inferiority RCT.
    Ross JD; Harding J; Duley L; Montgomery AA; Hepburn T; Tan W; Brittain C; Meakin G; Sprange K; Thandi S; Jackson L; Roberts T; Wilson J; White J; Dewsnap C; Cole M; Lawrence T
    Health Technol Assess; 2019 May; 23(20):1-104. PubMed ID: 31099330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibility/resistance and NG-MAST characterisation of Neisseria gonorrhoeae in Belarus, Eastern Europe, 2010-2013.
    Lebedzeu F; Golparian D; Titov L; Pankratava N; Glazkova S; Shimanskaya I; Charniakova N; Lukyanau A; Domeika M; Unemo M
    BMC Infect Dis; 2015 Jan; 15():29. PubMed ID: 25637258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.
    Wind CM; Schim van der Loeff MF; van Dam AP; de Vries HJ; van der Helm JJ
    Euro Surveill; 2017 Jan; 22(1):. PubMed ID: 28079519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Australian Gonococcal Surveillance Programme, 1 April to 30 June 2015.
    Lahra MM; Enriquez RP;
    Commun Dis Intell Q Rep; 2015 Dec; 39(4):E628-30. PubMed ID: 26779739
    [No Abstract]   [Full Text] [Related]  

  • 30. Complete ciprofloxacin resistance in gonococcal isolates in an urban Ugandan clinic: findings from a cross-sectional study.
    Mabonga E; Parkes-Ratanshi R; Riedel S; Nabweyambo S; Mbabazi O; Taylor C; Gaydos C; Manabe YC
    Int J STD AIDS; 2019 Mar; 30(3):256-263. PubMed ID: 30392463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts.
    Unemo M; Lahra MM; Cole M; Galarza P; Ndowa F; Martin I; Dillon JR; Ramon-Pardo P; Bolan G; Wi T
    Sex Health; 2019 Sep; 16(5):412-425. PubMed ID: 31437420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial susceptibility assays for Neisseria gonorrhoeae: a proof-of-principle population-based retrospective analysis.
    Bell SFE; Ware RS; Lewis DA; Lahra MM; Whiley DM
    Lancet Microbe; 2023 Jul; 4(7):e544-e551. PubMed ID: 37336225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Rapid Susceptibility Testing and Antibiotic Selection Strategy on the Emergence and Spread of Antibiotic Resistance in Gonorrhea.
    Tuite AR; Gift TL; Chesson HW; Hsu K; Salomon JA; Grad YH
    J Infect Dis; 2017 Nov; 216(9):1141-1149. PubMed ID: 28968710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in antimicrobial resistance in Neisseria gonorrhoeae and molecular characteristics of N. gonorrhoeae with decreased susceptibility to ceftriaxone in Shandong, China, 2007 to 2014.
    Zhao L; Liu A; Li R; Zhao S
    Int J Antimicrob Agents; 2018 Jan; 51(1):52-56. PubMed ID: 28729124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe.
    Cole MJ; Spiteri G; Chisholm SA; Hoffmann S; Ison CA; Unemo M; Van de Laar M
    Euro Surveill; 2014 Nov; 19(45):20955. PubMed ID: 25411689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidrug-resistant
    Terkelsen D; Tolstrup J; Johnsen CH; Lund O; Larsen HK; Worning P; Unemo M; Westh H
    Euro Surveill; 2017 Oct; 22(42):. PubMed ID: 29067905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Cost Analysis of Gyrase A Testing and Targeted Ciprofloxacin Therapy Versus Recommended 2-Drug Therapy for Neisseria gonorrhoeae Infection.
    Allan-Blitz LT; Hemarajata P; Humphries RM; Wynn A; Segura ER; Klausner JD
    Sex Transm Dis; 2018 Feb; 45(2):87-91. PubMed ID: 29329176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is previous azithromycin treatment associated with azithromycin resistance in
    Clifton S; Town K; Furegato M; Cole M; Mohammed H; Woodhall SC; Kevin Dunbar J; Fifer H; Hughes G
    Sex Transm Infect; 2018 Sep; 94(6):421-426. PubMed ID: 29511067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there an association between previous infection with
    Allen H; Merrick R; Ivanov Z; Pitt R; Mohammed H; Sinka K; Hughes G; Fifer H; Cole MJ
    Sex Transm Infect; 2023 Feb; 99(1):1-6. PubMed ID: 35246477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring antimicrobial resistance in Neisseria gonorrhoeae in selected countries of the WHO South-East Asia Region between 2009 and 2012: a retrospective analysis.
    Bala M; Kakran M; Singh V; Sood S; Ramesh V;
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv28-35. PubMed ID: 24243876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.